Related Experiment Video
Updated: Sep 14, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Post-Transplant Lymphoproliferative Disorder Presenting as Biventricular Failure After Heart Transplantation
Ye Chan Kim1, David Hong1, Jeong Hoon Yang1
1Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Background:
The diagnosis of post-transplant lymphoproliferative disorder (PTLD) is challenging because of its diverse clinical presentations.
Case Summary:
A 65-year-old man, previously stable 61 months after heart transplantation for dilated cardiomyopathy, presented with biventricular failure and worsening dyspnea. Given the acute decline in graft function, acute rejection was suspected, and rejection therapy was initiated. However, the patient showed no clinical improvement, and he required venoarterial extracorporeal membrane oxygenation support as a bridge to redo heart transplantation. Pathologic evaluation of the explanted heart revealed a diagnosis of PTLD.
Discussion:
This case underscores importance of recognizing PTLD as a potential cause of graft dysfunction in heart transplant recipients, particularly when rejection therapy is ineffective and biopsy findings are atypical. Further research is necessary to establish optimal treatment approaches.
Take-Home Messages:
PTLD can mimic acute rejection in heart transplant recipients, thus necessitating thorough histopathologic evaluation. Effective management, including tailored immunosuppressive strategy following retransplantation, needs further investigation.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations

